| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/26/2008 | WO2008076458A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 06/26/2008 | WO2008076046A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones |
| 06/26/2008 | WO2008076045A1 Novel 2-amino- 5-aryl-imidazol-4 -ones |
| 06/26/2008 | WO2008076044A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones |
| 06/26/2008 | WO2008076043A1 Novel 2-amino-5,5-diaryl-imidazol-4-ones |
| 06/26/2008 | WO2008075997A1 Method for treating opioid withdrawal syndrome |
| 06/26/2008 | WO2008075993A1 The use of diethylamine as analgesic in pharmaceutical preparations |
| 06/26/2008 | WO2008075978A2 An extract |
| 06/26/2008 | WO2008075621A1 Antacid |
| 06/26/2008 | WO2008075372A1 Controlled release dosage forms of zolpidem |
| 06/26/2008 | WO2008074896A1 Compositions and methods for treatment of chronic neurological disorders |
| 06/26/2008 | WO2008074816A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 06/26/2008 | WO2008074814A1 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 06/26/2008 | WO2008074813A2 Optiogenin for the treatment of neural diseases |
| 06/26/2008 | WO2008074798A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | WO2008074797A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | WO2008074716A1 Azabicyclic compounds as serotonine, dopamine and norepinephrine re-uptake inhibitors |
| 06/26/2008 | WO2008074697A1 Polymorphs of a mglur5 receptor antagonist |
| 06/26/2008 | WO2008074679A2 4-imidazolines as taar's ligands |
| 06/26/2008 | WO2008074420A1 Plants extracts for use in brain modulation |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008057930A3 Methods of treating neuropathic pain with retinoic acid receptor agonists |
| 06/26/2008 | WO2008048121A3 Macrocyclic cysteine protease inhibitors and compositions thereof |
| 06/26/2008 | WO2008046228A8 Compounds for stimulating p-glycoprotein function and uses thereof |
| 06/26/2008 | WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives |
| 06/26/2008 | WO2008011503A3 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | WO2007135193A3 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means |
| 06/26/2008 | WO2007103221A3 An improved process for the preparation of armodafinil |
| 06/26/2008 | WO2007073175A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 06/26/2008 | WO2007062862A3 Use of calmodulin inhibitors for the treatment of neurodegenerative disorders |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080154037 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 06/26/2008 | US20080153919 Milnacipran; sub-class of dual serotonin norepinephrine reuptake inhibitors characterized by a non-tricyclic structure and inhibit the reuptake of norepinephrine to an equal or greater extent than they inhibit the reuptake of serotonin; with gabapentin, pregabalin; no phenylalanine, tyrosine, tryptophan |
| 06/26/2008 | US20080153918 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing |
| 06/26/2008 | US20080153917 Sigma Receptor Ligands |
| 06/26/2008 | US20080153910 Lysine in therapeutic angiogenesis for cardiac and cerebral/neural reperfusion |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153897 Administering creatine pyroglutamate to improve neuron health; improving cognitive functions and preventing and fighting the onset of stress and its deleterious effects on mental and physical performances. |
| 06/26/2008 | US20080153896 Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof |
| 06/26/2008 | US20080153894 Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153890 Phosphinic Amino Acid Compounds |
| 06/26/2008 | US20080153886 4-Benzyl-[1,2,4]thiadiazolidine-3,5-dione or thione derivatives are used to treat nerve damage associated with prion diseases, Creutzfeld-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, muscular dystrophy, diabetic neuropathy, optic nerve injury, glaucoma, depression, bipolar disease, and ADT |
| 06/26/2008 | US20080153883 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 06/26/2008 | US20080153879 Method of managing or treating pain |
| 06/26/2008 | US20080153874 Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| 06/26/2008 | US20080153873 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/26/2008 | US20080153870 Cocaine receptor binding ligands |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153868 Substituted Tetrahydroisoquinolines as Beta-secretase Inhibitors |
| 06/26/2008 | US20080153867 Alzheimer's disease, cognitive disorders, memory disorders, dementia, attention deficit disorder, traumatic brain injury, drug dependence, addiction; -chloro-N-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazolyl]-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptylamino]methylene}benzene-sulfonamide |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153863 Spiropiperidine derivatives |
| 06/26/2008 | US20080153862 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153861 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153860 3H-(4's)-1'-azaspiro[benzofuran-2,4']-tricyclo[3.3.1.13,7]decane; for therapy of memory disorder, cognitive disorder, neurodegeneration, and neurodevelopmental disorder; attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153851 Cycloalkyl Piperidine Tachykinin Receptor Antagonists |
| 06/26/2008 | US20080153848 Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine |
| 06/26/2008 | US20080153846 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153833 Substituted pteridines for the treatment of inflammatory diseases |
| 06/26/2008 | US20080153830 methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using alpha -adrenergic antagonists and beta -adrenergic agonists (particularly beta 2-adrenergic agonists) alone or in combination. |
| 06/26/2008 | US20080153828 Imidazopyridazine Compounds |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153820 pharmaceutically acceptable salt thereof or prodrug thereof, and the use thereof in therapy and in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, |
| 06/26/2008 | US20080153817 Treatment for Alzheimer's Disease and Related Conditions |
| 06/26/2008 | US20080153814 8-Chloro-2,3-Benzodiazepine Derivatives |
| 06/26/2008 | US20080153811 methods for treating, managing and preventing cognitive impairment associated with various diseases and disorders, age-associated memory impairment, and dementia. |
| 06/26/2008 | US20080153810 novel indazole that may be used as melanin concentrating hormone receptor ligands, methods of preparing such compounds, compositions containing such compounds, and methods of using such compounds to treat MCH related disorders. |
| 06/26/2008 | US20080153808 pharmaceutical composition comprising a serotonin-norepinephrine reuptake inhibitor and a pan-alpha-2 receptor agonist. The composition is effective for treating chronic pain, and methods of treating pain using the composition and compounds comprising it |
| 06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |
| 06/26/2008 | US20080153768 Treatment of neurological disorders by dsrna administration |
| 06/26/2008 | US20080153759 Treatment methods using polypeptides related to amyloid precursor protein |
| 06/26/2008 | US20080153758 6-[Amino(4-chlorophenyl)-1-methyl-1H-imidazol-5-ylmethyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone; (2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentyl]oxy]-1-oxo-3-phenylpropyl]amino]-4-(methylsulfonyl)-butanoic acid 1-methylethyl ester; exhibit potent activity agains |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153167 In vivo amplification of neural progenitor cells |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080152726 Using polyunsaturated fatty acid and agent which adjust methionine metabolism such as vitamin b6, b12, folic acid; Parkinson's and Huntington's disease; antiepileptic agents; schizophrenia; antiepileptic agents; sleep disorders; antidepressants |
| 06/26/2008 | US20080152709 Clonidine composition and method of use |
| 06/26/2008 | US20080152693 A dopamine agonist and a biodegradable polymer; preferably ropinirole and polylactic acid; side effect reduction; Parkinson's Disease, Attention Deficit Disorder, autism, Asperger's Syndrome, erectile dysfunction, restless leg syndrome, or hyperprolactinemia |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152667 Neurotoxin/immunoglobulin fusion for use in treatment and prevention of pain and respiratory system disorders |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152645 Genetically Encoded Multifunctional Compositions Bidrectionally Transported Between Peripheral Blood and the CNS |
| 06/26/2008 | US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy |
| 06/26/2008 | DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration |
| 06/26/2008 | CA2673454A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | CA2673444A1 Polymorphs of a mglur5 receptor antagonist |
| 06/26/2008 | CA2673336A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 06/26/2008 | CA2673315A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/26/2008 | CA2672898A1 Methods of neuroprotection by cyclin-dependent kinase inhibition |
| 06/26/2008 | CA2672814A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |